Ranbaxy and EPIRUS sign licensing agreement for biosimilar product
Ranbaxy to market in India and other emerging markets, after approval
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Biocon launches CANMAb for breast cancer
CANMAb, developed jointly by Biocon and Mylan under a global partnership
Business Monitor releases report on India’s lifesciences sector
Report mentions that the government is impeding the development of its pharma sector, mainly due to extensive bureaucracy and poor…
Aurobindo’s European arm to acquire Actavis’ ops in 7 Euro nations
The acquisition will make Aurobindo one of the leading Indian pharmaceutical companies in Europe
Lilly India and Boehringer Ingelheim India launch re-usable insulin pen
HumaPen Savvio is designed to resemble a small personal accessory rather than a medical device to help manage diabetes discreetly
Gilead names Mylan as exclusive branded medicines business partner for India
Under the agreement, Mylan will market and distribute in India certain Gilead medications
IPM clocks Rs 6256 crores in December 2013
The IPM market grew for the second consecutive month, clocking a growth of 8.2 per cent
4th Annual Vaccine World Summit India 2014 to be held in Hyderabad
Slated to be held from March 4-6, 2014, it would connect key stakeholders, to facilitate learning, as well as sharing of…
Santa Fe joins hands with BioAsia for bilateral collaboration
40 member business delegation from Argentina to participate at BioAsia
’Biotech for a Better Tomorrow’ key theme at Bangalore India Bio
Delegations from various countries are expected, with key participation from the European Union, Scotland and the Czech Republic